Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Deferred Taxes (2017)

Phio Pharmaceuticals' Deferred Taxes history spans 1 years, with the latest figure at -$1.6 million for Q1 2017.

  • For Q1 2017, Deferred Taxes changed N/A year-over-year to -$1.6 million; the TTM value through Dec 2017 reached -$1.6 million, changed N/A, while the annual FY2017 figure was -$1.6 million, N/A changed from the prior year.
  • Deferred Taxes reached -$1.6 million in Q1 2017 per PHIO's latest filing.
  • In the past five years, Deferred Taxes ranged from a high of -$1.6 million in Q1 2017 to a low of -$1.6 million in Q1 2017.